Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Surgical Wound Infection 1 Skin Neoplasms 1 Postoperative Complications 1 Adenocarcinoma 1

Interventions

Oxaliplatin 6 Capecitabine 6 Fluorouracil 5 Leucovorin 4 trastuzumab deruxtecan 3 pembrolizumab 3 cemiplimab 3 Cisplatin 3 zolbetuximab 2 fludarabine 2 durvalumab 2 Trastuzumab 2 Ramucirumab 2 Paclitaxel 2 Cyclophosphamide 2 tucatinib 1 repotrectinib 1 paricalcitol 1 lenvatinib 1 enzalutamide 1 darolutamide 1 atezolizumab 1 alpha-2'-deoxythioguanosine 1 aldesleukin 1 Vinorelbine 1 Transurethral Resection of Prostate 1 Taxes 1 Radiosurgery 1 Radiofrequency Ablation 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Negative-Pressure Wound Therapy × 30 days × Clear all

NCT07489820 2026-05-22

AAPICO

Centre Hospitalier Departemental Vendee

Phase NA Not yet recruiting

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡